Newly Bankrupt Angiotech Ends Merger Fight For $6M
Angiotech Pharmaceuticals Inc. on Friday announced plans to slash $250 million in debt through bankruptcy, at the same time saying it had agreed to a $6 million deal with former Quill...To view the full article, register now.
Already a subscriber? Click here to view full article